The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Over the past few years, the role of intestinal alkaline phosphatase (IAP) as a crucial mucosal defence factor essential for maintaining gut homeostasis has been established. IAP is an important apical brush border enzyme expressed throughout the gastrointestinal tract and secreted both into the intestinal lumen and into the bloodstream. IAP exerts its effects through dephosphorylation of proinflammatory molecules including lipopolysaccharide (LPS), flagellin, and adenosine triphosphate (ATP) released from cells during stressful events. Diminished activity of IAP could increase the risk of disease through changes in the microbiome, intestinal inflammation, and intestinal permeability. Exogenous IAP exerts a protective effect against intestinal and systemic inflammation in a variety of diseases and represents a potential therapeutic agent in diseases driven by gut barrier dysfunction such as IBD. The intestinal protective mechanisms are impaired in IBD patients due to lower synthesis and activity of endogenous IAP, but the pathomechanism of this enzyme deficiency remains unclear. IAP has been safely administered to humans and the human recombinant form of IAP has been developed. This review was designed to provide an update in recent research on the involvement of IAP in intestinal inflammatory processes with focus on IBD in experimental animal models and human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 1×
“An essential role of LPSwas confirmed by the observation that mice lacking TLR4, the receptor for LPS, are resistant to HFD-induced inflammation, obesity, and insulin resistance [80].”
BackgroundRetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Metabolic syndrome leads to type 2 diabetes, atherosclerosis, and nonalcoholic fatty liver disease [76, 77].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 2×
“Moreover, endotoxemia has been suggested to play a crucial role in pathogenesis of metabolic syndrome [78, 79].”
BackgroundGrundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833 · cited 1×
“The incidence rates and prevalence of IBD over the past 50 years have increased remarkably in countries that have adapted a “westernized” lifestyle [40, 41] characterized by serious modifications in dietary habits and decreased physical activity.”
BackgroundCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 2×
“Moreover, endotoxemia has been suggested to play a crucial role in pathogenesis of metabolic syndrome [78, 79].”
BackgroundUchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176 · cited 1×
“Sepsis is a predominant cause of acute kidney injury (AKI) in the intensive care unit [90] which is associated with a high mortality and an increased risk of developing chronic”
BackgroundAbraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256 · cited 1×
“as IAP activity against bacterial products, in particular LPS, have been shown to be an important factor underlying IBD pathogenesis [48, 49].”
BackgroundEpidemiology and Natural History of Inflammatory Bowel Diseases
Cosnes, J., Gower–Rousseau, C., Seksik, P., & Cortot, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.055 · Cited by 2,211 · cited 1×
“The incidence rates and prevalence of IBD over the past 50 years have increased remarkably in countries that have adapted a “westernized” lifestyle [40, 41] characterized by serious modifications in dietary habits and decreased physical activity.”
BackgroundThe history of toll-like receptors - redefining innate immunity
O'Neill, L. A. J., Golenbock, D., & Bowie, A. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3446 · Cited by 1,765 · cited 1×
“LPS could bind to LPS-binding protein (LBP) and the LBP-LPS complex is transferred to membrane-bound or soluble CD14, thereby enabling interactions with toll-like receptors (TLRs) on cell membranes [12].”
BackgroundMechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Bacterial endotoxin: molecular relationships of structure to activity and function
Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119492 · Cited by 1,607
Cario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,246
Recognition of lipopolysaccharide pattern by TLR4 complexes
Park, B. S., & Lee, J.-O. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.97 · Cited by 1,234 · cited 1×
“The two phosphate groups of the LPS lipid A moiety support stable binding to the receptor complex, and the dephosphorylation of lipid A leads to the amelioration of inflammatory activity of LPS [20].”
BackgroundZeissig, S., Bürgel, N., Günzel, D., Richter, J., Mankertz, J., Wahnschaffe, U., Kroesen, A. J., Zeitz, M., Fromm, M., & Schulzke, J.-D. (2007) · Gut · doi:10.1136/gut.2006.094375 · Cited by 1,223
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160 · cited 1×
“Dysbiosis and decreased complexity of the gut microbial ecosystem are common features in IBD patients [50].”
Backgroundde La Serre, C. B., Ellis, C. L., Lee, J., Hartman, A. L., Rutledge, J. C., & Raybould, H. E. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2010 · Cited by 949
Bates, J. M., Akerlund, J., Mittge, E., & Guillemin, K. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.10.010 · Cited by 751 · cited 2×
“They observed that IAP-knockout mice exhibited more ATP in their luminal contents than the wild-type mice [32].”
BackgroundGuo, S., Al-Sadi, R., Said, H. M., & Ma, T. Y. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.10.014 · Cited by 719 · cited 1×
“[72] demonstrated that LPS causes an increase in intestinal tight-junction permeability in vitro and in vivo via an intracellular mechanism involving TLR-4-dependent upregulation of CD14 membrane expression.”
BackgroundMichielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease
Brown, K., DeCoffe, D., Molcan, E., & Gibson, D. L. (2012) · Nutrients · doi:10.3390/nu4081095 · Cited by 676
Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia
Moreira, A. P. B., Texeira, T. F. S., Ferreira, A. B., do Carmo Gouveia Peluzio, M., & de Cássia Gonçalves Alfenas, R. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001213 · Cited by 655
Epithelial Barriers in Homeostasis and Disease
Marchiando, A. M., Graham, W. V., & Turner, J. R. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092135 · Cited by 613 · cited 1×
“Molecular components of tight junctions include integral membrane proteins: occludins, claudins, and junctional adhesion molecules (JAM) as well their scaffolding proteins (zonula occludens (ZO) proteins) [68].”
BackgroundRole of Toll-Like Receptors in Pathogen Recognition
Janssens, S., & Beyaert, R. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.637-646.2003 · Cited by 574 · cited 2×
“Upon activation by LPS, toll-like receptor 4 (TLR4) initiates a signalling cascade leading to the release of proinflammatory cytokines as tumour necrosis factorα (TNF-α), interleukin- (IL-) 1, IL-6, IL-8, and IL-12 [13].”
BackgroundMartinez-Medina, M., Denizot, J., Dreux, N., Robin, F., Billard, E., Bonnet, R., Darfeuille-Michaud, A., & Barnich, N. (2014) · Gut · doi:10.1136/gutjnl-2012-304119 · Cited by 539 · cited 1×
“This effect not only compromised the gut mucosal integrity but also promoted the mucosal entry of pathogenic agents from the intestinal lumen into the bloodstream [46, 47].”
BackgroundIntestinal barrier in inflammatory bowel disease
Antoni, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1165 · Cited by 413
Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition
Goldberg, R. F., Austen, W. G., Zhang, X., Munene, G., Mostafa, G., Biswas, S., McCormack, M., Eberlin, K. R., Nguyen, J. T., Tatlidede, H. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712140105 · Cited by 369 · cited 3×
“Initiation ofMyD88dependent pathway could lead to activation of nuclear factor𝜅B (NF-𝜅B) and release of several proinflammatory cytokines [15].”
BackgroundLallès, J.-P. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00292.x · Cited by 355 · cited 2×
“Consequently, the dephosphorylated LPS due to IAP is no longer able to cause TLR4 stimulation and may even block its binding to receptor acting as an antagonist of TLR-4 receptors [4, 10, 21].”
BackgroundIntestinal alkaline phosphatase: novel functions and protective effects
Lallès, J.-P. (2014) · Nutrition Reviews · doi:10.1111/nure.12082 · Cited by 326 · cited 1×
“Intestinal alkaline phosphatase (IAP) exhibits its biological activity in alkaline conditions with highest activity at a pH 9.7 [1, 3–5].”
BackgroundInfluentialTight junction, selective permeability, and related diseases
Krug, S. M., Schulzke, J. D., & Fromm, M. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.09.002 · Cited by 306
Intestinal alkaline phosphatase prevents metabolic syndrome in mice
Kaliannan, K., Hamarneh, S. R., Economopoulos, K. P., Nasrin Alam, S., Moaven, O., Patel, P., Malo, N. S., Ray, M., Abtahi, S. M., Muhammad, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220180110 · Cited by 262 · cited 3×
“the development of metabolic syndrome [34].”
BackgroundInfluentialVetrano, S., Rescigno, M., Rosaria Cera, M., Correale, C., Rumio, C., Doni, A., Fantini, M., Sturm, A., Borroni, E., Repici, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.002 · Cited by 254
Intestinal alkaline phosphatase: a summary of its role in clinical disease
Fawley, J., & Gourlay, D. M. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2015.12.008 · Cited by 230 · cited 4×
“The IAP is expressed throughout the intestine with the highest expression in the duodenum, whereas its phosphatase activity is highest in the terminal ileum [7].”
BackgroundInfluentialIntestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota
Malo, M. S., Alam, S. N., Mostafa, G., Zeller, S. J., Johnson, P. V., Mohammad, N., Chen, K. T., Moss, A. K., Ramasamy, S., Faruqui, A., et al. (2010) · Gut · doi:10.1136/gut.2010.211706 · Cited by 216 · cited 3×
“They have concluded that IAP is involved in the maintenance of normal gut microbial homeostasis and suggested the therapeutic potential of this enzyme [31].”
BackgroundRemoval of Phosphate from Lipid A as a Strategy to Detoxify Lipopolysaccharide
Bentala, H., Verweij, W. R., der Vlag, A. H.-V., van Loenen-Weemaes, A. M., Meijer, D. K. F., & Poelstra, K. (2002) · Shock · doi:10.1097/00024382-200212000-00013 · Cited by 205
Wright, E. K., Kamm, M. A., Teo, S. M., Inouye, M., Wagner, J., & Kirkwood, C. D. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000382 · Cited by 202
Szebeni, B., Veres, G., Dezsõfi, A., Rusai, K., Vannay, Á., Mraz, M., Majorova, E., & Arató, A. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03531.x · Cited by 194 · cited 2×
“IBD patients have a significantly higher TLR4 expression when compared to healthy controls [51, 52].”
BackgroundPickkers, P., Heemskerk, S., Schouten, J., Laterre, P.-F., Vincent, J.-L., Beishuizen, A., Jorens, P. G., Spapen, H., Bulitta, M., Peters, W. H., et al. (2012) · Critical Care · doi:10.1186/cc11159 · Cited by 194 · cited 4×
“Sepsis is a predominant cause of acute kidney injury (AKI) in the intensive care unit [90] which is associated with a high mortality and an increased risk of developing chronic kidney failure in survivors.”
InfluentialMyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction
Warner, N., & Núñez, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203103 · Cited by 189
Rethinking Regenerative Medicine: A Macrophage-Centered Approach
Brown, B. N., Sicari, B. M., & Badylak, S. F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00510 · Cited by 187
Campbell, E. L., MacManus, C. F., Kominsky, D. J., Keely, S., Glover, L. E., Bowers, B. E., Scully, M., Bruyninckx, W. J., & Colgan, S. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914730107 · Cited by 186 · cited 1×
“Based on clinical studies [19, 28, 29] and animal experiments [6, 19, 25, 26, 74, 75], Lallès [10] observed that IAP is reduced, but TNAP is upregulated in IBD.”
BackgroundThe role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation
Gribar, S. C., Anand, R. J., Sodhi, C. P., & Hackam, D. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607358 · Cited by 182
Brzozowski, B., Mazur-Bialy, A., Pajdo, R., Kwiecien, S., Bilski, J., Zwolinska-Wcislo, M., Mach, T., & Brzozowski, T. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160404124127 · Cited by 179
Self-citationKoyama, I., Matsunaga, T., Harada, T., Hokari, S., & Komoda, T. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00330-2 · Cited by 178 · cited 1×
“The LPS interaction with the IAP has been supported by the fact that the administration of exogenous IAP attenuated LPS-mediated toxicity [22, 23] (Figure 1).”
BackgroundBeumer, C., Wulferink, M., Raaben, W., Fiechter, D., Brands, R., & Seinen, W. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056606 · Cited by 174 · cited 1×
“The LPS interaction with the IAP has been supported by the fact that the administration of exogenous IAP attenuated LPS-mediated toxicity [22, 23] (Figure 1).”
BackgroundRole of alkaline phosphatase in colitis in man and rats
Tuin, A., Poelstra, K., de Jager-Krikken, A., Bok, L., Raaben, W., Velders, M. P., & Dijkstra, G. (2009) · Gut · doi:10.1136/gut.2007.128868 · Cited by 171 · cited 5×
“Consequently, the impairment of the intestinal protective mechanismobserved in patientswith IBDhas been attributed to the lower intestinal synthesis and activity of endogenous IAP, but the pathomechanismof this disorderwith the respect to IAP deficiency has not been fully explored [19].”
BackgroundInfluentialMankertz, J., Amasheh, M., Krug, S. M., Fromm, A., Amasheh, S., Hillenbrand, B., Tavalali, S., Fromm, M., & Schulzke, J. D. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0751-8 · Cited by 162
Inflammatory bowel disease: an impaired barrier disease
Jäger, S., Stange, E. F., & Wehkamp, J. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-1030-9 · Cited by 158
The Role of Physical Exercise in Inflammatory Bowel Disease
Bilski, J., Brzozowski, B., Mazur-Biały, A. I., Śliwowski, Z., & Brzozowski, T. (2014) · BioMed Research International · doi:10.1155/2014/429031 · Cited by 153
Self-citationAlkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients*
Heemskerk, S., Masereeuw, R., Moesker, O., Bouw, M. P. W. J. M., van der Hoeven, J. G., Peters, W. H. M., Rüssel, F. G. M., & Pickkers, P. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819598af · Cited by 150 · cited 4×
“Sepsis is a predominant cause of acute kidney injury (AKI) in the intensive care unit [90] which is associated with a high mortality and an increased risk of developing chronic kidney failure in survivors.”
InfluentialInterplay between intestinal alkaline phosphatase, diet, gut microbes and immunity
Estaki, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15650 · Cited by 146 · cited 1×
“Endotoxemia resulting from the abundance of LPS in the blood stream can lead to a septic shock, if the immune response is severely pronounced but at lower levels of immunity, it can also stimulatemild chronic inflammatory response associated with chronic inflammatory diseases [14].”
BackgroundAdipose Tissue and Inflammatory Bowel Disease Pathogenesis
Fink, C., Karagiannides, I., Bakirtzi, K., & Pothoulakis, C. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22893 · Cited by 138 · cited 1×
“Because of the formation of so-called “creeping fat,” this increase in proinflammatory cytokines can be, at least in part, caused by LPS [57, 59, 60], but the IAP administration is believed to reduce this process.”
BackgroundIntestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels
Liu, W., Hu, D., Huo, H., Zhang, W., Adiliaghdam, F., Morrison, S., Ramirez, J. M., Gul, S. S., Hamarneh, S. R., & Hodin, R. A. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.12.006 · Cited by 131 · cited 2×
“[73] have studied the relationship between IAP deficiency and IAP overproduction and their effect on tight-junction protein (TJP) levels and function.”
BackgroundKredel, L. I., Batra, A., Stroh, T., Kühl, A. A., Zeitz, M., Erben, U., & Siegmund, B. (2012) · Gut · doi:10.1136/gutjnl-2011-301424 · Cited by 131 · cited 1×
“Because of the formation of so-called “creeping fat,” this increase in proinflammatory cytokines can be, at least in part, caused by LPS [57, 59, 60], but the IAP administration is believed to reduce this process.”
BackgroundMesquida, J., Saludes, P., Gruartmoner, G., Espinal, C., Torrents, E., Baigorri, F., & Artigas, A. (2015) · Critical Care · doi:10.1186/s13054-015-0858-0 · Cited by 126
Malo, M. S., Moaven, O., Muhammad, N., Biswas, B., Alam, S. N., Economopoulos, K. P., Gul, S. S., Hamarneh, S. R., Malo, N. S., Teshager, A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00357.2013 · Cited by 114 · cited 3×
“The mechanisms illustrated in this figure which are described in the text were inspired by [8, 9] cited in this review.”
BackgroundCan exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence
Bilski, J., Mazur-Biały, A. I., Brzozowski, B., Magierowski, M., Zahradnik-Bilska, J., Wójcik-Grzybek, D., Magierowska, K., Kwiecień, S., Mach, T., & Brzozowski, T. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.04.009 · Cited by 107
Self-citationLukáš, M., Drastich, P., Konečný, M., Gionchetti, P., Urban, O., Cantoni, F., Bortlík, M., Ďuricová, D., & Bulitta, M. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21161 · Cited by 105 · cited 4×
“Based on clinical studies [19, 28, 29] and animal experiments [6, 19, 25, 26, 74, 75], Lallès [10] observed that IAP is reduced, but TNAP is upregulated in IBD.”
BackgroundResultInfluentialIntestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis
Ramasamy, S., Nguyen, D. D., Eston, M. A., Alam, S. N., Kuhnen, A. H., Ebrahimi, F., Biswas, B., Mostafa, G., Chen, K. T., Kaliannan, K., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21377 · Cited by 105 · cited 4×
“Based on clinical studies [19, 28, 29] and animal experiments [6, 19, 25, 26, 74, 75], Lallès [10] observed that IAP is reduced, but TNAP is upregulated in IBD.”
BackgroundMethodInfluentialChen, K. T., Malo, M. S., Moss, A. K., Zeller, S., Johnson, P., Ebrahimi, F., Mostafa, G., Alam, S. N., Ramasamy, S., Warren, H. S., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00364.2009 · Cited by 104
Peters, E., Geraci, S., Heemskerk, S., Wilmer, M. J. G., Bilos, A., Kraenzlin, B., Gretz, N., Pickkers, P., & Masereeuw, R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13261 · Cited by 99 · cited 4×
“Sepsis is a predominant cause of acute kidney injury (AKI) in the intensive care unit [90] which is associated with a high mortality and an increased risk of developing chronic kidney failure in survivors.”
BackgroundInfluentialFood and the gut microbiota in inflammatory bowel diseases: a critical connection
Albenberg, L. G., Lewis, J. D., & Wu, G. D. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328354586f · Cited by 98 · cited 1×
“Dietary patterns characteristic for industrialized developed countriesmight promote a dysbiosis in genetically predisposed subjects [45].”
BackgroundPeters, E., Heemskerk, S., Masereeuw, R., & Pickkers, P. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.11.027 · Cited by 96 · cited 7×
“This inhibition could be reversed by exogenous IAP,which dephosphorylates freeATP [9].”
BackgroundInfluentialde Medina, F. S., Martínez‐Augustin, O., González, R., Ballester, I., Nieto, A., Gálvez, J., & Zarzuelo, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.045 · Cited by 93
Increased Mucosal Expression of Toll‐like Receptor (TLR)2 and TLR4 in Coeliac Disease
Szebeni, B., Veres, G., Dezsőfi, A., Rusai, K., Vannay, Á., Bokodi, G., Vásárhelyi, B., Korponay‐Szabó, I., Tulassay, T., & Arató, A. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318064514a · Cited by 92 · cited 1×
“The same group also found our increased mRNA and protein levels of TLR4 in the duodenal mucosa of newly diagnosed celiac paediatric patients [83].”
BackgroundA Role for Intestinal Alkaline Phosphatase in the Maintenance of Local Gut Immunity
Chen, K. T., Malo, M. S., Beasley-Topliffe, L. K., Poelstra, K., Millan, J. L., Mostafa, G., Alam, S. N., Ramasamy, S., Warren, H. S., Hohmann, E. L., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1396-x · Cited by 90
Visceral fat and gut inflammation
Drouet, M., Dubuquoy, L., Desreumaux, P., & Bertin, B. (2011) · Nutrition · doi:10.1016/j.nut.2011.09.009 · Cited by 77
Yang, Y., Wandler, A. M., Postlethwait, J. H., & Guillemin, K. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00314 · Cited by 75 · cited 1×
“LPS is a major component of the outer membrane of Gram-negative bacteria [11] which compose a substantial part of the mammalian intestinal microbiota [2].”
BackgroundCatalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential
Kiffer-Moreira, T., Sheen, C. R., Gasque, K. C. D. S., Bolean, M., Ciancaglini, P., van Elsas, A., Hoylaerts, M., & Millán, J. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089374 · Cited by 71 · cited 1×
“recombinant AP (recAP) has been recently developed [95] and its protective effects have been confirmed in studies in vitro and in vivo in rat model of LPS-induced AKI [96].”
BackgroundAlpers, D., Zhang, Y., & Ahnen, D. J. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.6.e1205 · Cited by 68
Bilski, J., Mazur-Biały, A. I., Wierdak, M., & Brzozowski, T. (2013) · PubMed · Cited by 66
Self-citationIntestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.
Molnár, K., Vannay, Á., Szebeni, B., Bánki, N. F., Sziksz, E., Cseh, Á., Győrffy, H., Lakatos, P. L., Papp, M., Arató, A., et al. (2012) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v18.i25.3254 · Cited by 64
Intestinal Alkaline Phosphatase Prevents Antibiotic-Induced Susceptibility to Enteric Pathogens
Alam, S. N., Yammine, H., Moaven, O., Ahmed, R., Kuhnen, A. H., Biswas, B., Muhammad, N., Biswas, R., Raychowdhury, A., Kaliannan, K., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31828fae14 · Cited by 64 · cited 1×
“Exogenous IAP had also protective action in mice with antibiotic-associated diarrhoea [86].”
BackgroundImpaired Mucosal Barrier Function in the Small Intestine of the Cystic Fibrosis Mouse
Lisle, R. C. D., Mueller, R., & Boyd, M. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318219c397 · Cited by 58
Pathogenesis of Crohn’s disease: Bug or no bug
Boscá-Watts, M. M., Tosca, J., Anton, R., Mora, M., Minguez, M., & Mora, F. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i1.1 · Cited by 56
Bilski, J., Mazur-Bialy, A. I., Brzozowski, B., Magierowski, M., Jasnos, K., Krzysiek-Maczka, G., Urbanczyk, K., Ptak-Belowska, A., Zwolinska-Wcislo, M., Mach, T., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/605071 · Cited by 49
Self-citationRiggle, K. M., Rentea, R. M., Welak, S. R., Pritchard, K. A., Oldham, K. T., & Gourlay, D. M. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.10.042 · Cited by 42
Prevention of antibiotic‐associated metabolic syndrome in mice by intestinal alkaline phosphatase
Economopoulos, K. P., Ward, N. L., Phillips, C. D., Teshager, A., Patel, P. Y., Mohamed, M. M., Hakimian, S., Cox, S. B., Ahmed, R., Moaven, O., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12645 · Cited by 41 · cited 2×
“This has been referred to a decrease in the IAP expression and activity in celiac paediatric patients [81].”
BackgroundBacterial Translocation – Impact on the Adipocyte Compartment
Kruis, T., Batra, A., & Siegmund, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00510 · Cited by 37 · cited 1×
“Because of the formation of so-called “creeping fat,” this increase in proinflammatory cytokines can be, at least in part, caused by LPS [57, 59, 60], but the IAP administration is believed to reduce this process.”
BackgroundReciprocal interaction of diet and microbiome in inflammatory bowel diseases
Schaubeck, M., & Haller, D. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000216 · Cited by 35
Lee, C., Chun, J., Hwang, S. W., Kang, S. J., Im, J. P., & Kim, J. S. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.02.003 · Cited by 30 · cited 2×
“[27] have employed the piroxicaminduced IL-10 knockout mouse model and observed the significant reduction in the severity of experimental colitis after oral administration of IAP.”
BackgroundMethodWang, W., Chen, S.-W., Zhu, J., Zuo, S., Ma, Y.-Y., Chen, Z., Zhang, J., Chen, G., Liu, Y., & Wang, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124835 · Cited by 29 · cited 1×
“[85] have shown a therapeutic effect of exogenous IAP in mouse model of peritonitis, as manifested by the”
BackgroundLallès, J. P. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00435.2013 · Cited by 26
Cited by
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Khare, V., Krnjic, A., Frick, A., Gmainer, C., Asboth, M., Jimenez, K., Lang, M., Baumgartner, M., Evstatiev, R., & Gasche, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39401-0 · Cited by 70
Metadata
- Authors
- Bilski, J., Mazur-Bialy, A., Wojcik, D., Zahradnik-Bilska, J., Brzozowski, B., Magierowski, M., Mach, T., Magierowska, K., & Brzozowski, T.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-9
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W2590939865
- Cited by
- 170
- References
- 85
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.